Granulocyte colony stimulating factor in acute liver failure and alcoholic hepatitis
In this study 4 groups have been taken. Two groups of cases including Alcoholic patients and acute liver failure which are given G-CSF therapy and two groups of controls given standard therapy. Primary end point is to see the mobilization of CD-34 hematopoietic cells and survival. Secondary end point is to see the clinical and biochemical improvement in liver functions.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
300 I.U twice daily for 5 days
Postgraduate Institute of Medical Education & Research Chandigarh India
Chandigarh, Chandigarh, India
RECRUITING• Mobilization of CD34 cells in the peripheral blood, a surrogate marker for hematopoietic stem cell mobilization
Time frame: 1 year
clinical and biochemical improvement in liver functions
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.